Sinopep Pharmaceutical Inc., located in Hangzhou,China, specializes in the
research and production of generic and custom peptides for pharmaceutical application.
Our comprehensive array of...
NanoBio Chemicals India Private Limited was conceived and founded in 2006.
Mission of NanoBio Chemicals is to be the foremost producer of high quality
nanoparticles using patented technology...
Camurus specializes in the development of pharmaceuticals based on advanced
and effective drug delivery solutions that optimize the bioavailability and
therapeutic performance of a wide range...
Adaptive Therapeutics Inc. (ATI) was founded in May 2002 with the closing of its Series A round of venture capital financing and began operations at its principal headquarters in San Diego, CA in July...
Nanoprobes was founded to develop the most sensitive reagents and technology for detecting biological molecules. Our unique gold labeling technology uses chemically cross-linked metal clusters and...
This article outlines a convenient mass-synthesis method for organic nanotubes which uses less than one thousandth of the solvent used in conventional methods, and the time required for the drying...
http://www.azonano.com/article.aspx?ArticleID=1686 | 10 Aug 2006
Nanotechnology Victoria ("NanoVic"), Monash University, and Swinburne University of Technology completed an agreement in December 2004 for joint investment in new equipment to make nanoarrays for the...
http://www.azonano.com/article.aspx?ArticleID=1274 | 21 Jun 2005
3D Matrix has created a system of peptides that self-assemble into strands. These then become framework for cells to grow into tissue. Posted August 21 2003
http://www.azonano.com/article.aspx?ArticleID=263 | 4 Dec 2003
Research in the field of nanobiotechnology could help to improve the ways in which cancer is detected and treated. Medical imaging, labeling methods, quantum dots, nanosensors, lab on a chip devices,...
http://www.azonano.com/article.aspx?ArticleID=1286 | 28 Jun 2005
The TATLYS project is developing a system for targeted release of drugs to break down human blood clots. Posted March 27 2003
http://www.azonano.com/article.aspx?ArticleID=325 | 17 Dec 2003